Arabic Arabic English English French French German German
dark

Ventyx Biosciences Appoints Martin D. Auster, M.D. as Chief Financial Officer

 Ventyx Biosciences, Inc. (“Ventyx”), a clinical-stage biopharmaceutical company advancing a pipeline of immune modulators to treat inflammatory diseases and autoimmune disorders, today announced the appointment of Martin D. Auster , M.D., as Chief Financial Officer.  Read More

Total
0
Shares
Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Post

Tetra Bio-Pharma Re-activates Veterinary Clinical Study in Companion Animals

Next Post

C4Diagnostics Announces CE Marking of C4Covid-19 HumanTM: a Covid-19 Saliva-Based Rapid Diagnostic Test

Related Posts
Total
0
Share